186 related articles for article (PubMed ID: 14606083)
1. Influence factors of serum fibrosis markers in liver fibrosis.
Tao J; Peng HQ; Cai WM; Dong FQ; Weng HL; Liu RH
World J Gastroenterol; 2003 Nov; 9(11):2497-500. PubMed ID: 14606083
[TBL] [Abstract][Full Text] [Related]
2. [Study on the influence factors of the serum fibrosis markers].
Cai WM; Tao J; Weng HL; Liu RH
Zhonghua Gan Zang Bing Za Zhi; 2003 Jan; 11(1):23-5. PubMed ID: 12546736
[TBL] [Abstract][Full Text] [Related]
3. Determination of serum fibrosis indexes in patients with chronic hepatitis and its significance.
Zheng M; Cai W; Weng H; Liu R
Chin Med J (Engl); 2003 Mar; 116(3):346-9. PubMed ID: 12781034
[TBL] [Abstract][Full Text] [Related]
4. The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis.
Xie SB; Yao JL; Zheng SS; Yao CL; Zheng RQ
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):202-6. PubMed ID: 14607739
[TBL] [Abstract][Full Text] [Related]
5. The relationship between staging of hepatic fibrosis and the levels of serum biochemistry.
Xu GG; Luo CY; Wu SM; Wang CL
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):246-8. PubMed ID: 14612277
[TBL] [Abstract][Full Text] [Related]
6. ROC curves in evaluation of serum fibrosis indices for hepatic fibrosis.
Zheng M; Cai WM; Weng HL; Liu RH
World J Gastroenterol; 2002 Dec; 8(6):1073-6. PubMed ID: 12439928
[TBL] [Abstract][Full Text] [Related]
7. [Determination and significance of serum markers for fibrosis in patients with chronic hepatitis].
Cai W; Zheng M; Weng H; Liu R
Zhonghua Nei Ke Za Zhi; 2001 Jul; 40(7):448-51. PubMed ID: 11798612
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of serum fibrosis markers in diagnosis of infantile hepatitis syndrome].
Deng WL; Xiong H; Wang LL; Zou XB
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Oct; 16(10):1029-32. PubMed ID: 25344185
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic values of serum levels of HA, PC III, C IV and LN to the liver fibrosis in children with beta-thalassemia major].
Xu HG; Fang JP; Huang SL; Li HG; Zhong FY; Guo HX; Su H
Zhonghua Er Ke Za Zhi; 2003 Aug; 41(8):603-6. PubMed ID: 14744384
[TBL] [Abstract][Full Text] [Related]
10. Liver Shear-Wave Velocity and Serum Fibrosis Markers to Diagnose Hepatic Fibrosis in Patients with Chronic Viral Hepatitis B.
Liu J; Ji Y; Ai H; Ning B; Zhao J; Zhang Y; Dun G
Korean J Radiol; 2016; 17(3):396-404. PubMed ID: 27134527
[TBL] [Abstract][Full Text] [Related]
11. Serum hyaluronic acid, procollagen type III and IV in histological diagnosis of liver fibrosis.
Xie SB; Yao JL; Zheng RQ; Peng XM; Gao ZL
Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):69-72. PubMed ID: 14607650
[TBL] [Abstract][Full Text] [Related]
12. Comparison of four markers of hepatic fibrosis and hepatic function indices in patients with liver cirrhosis and hepatoma.
Ma HY; Dong L; Quan SZ; Li RY; Wang XR
Ann Palliat Med; 2021 Apr; 10(4):4108-4121. PubMed ID: 33832299
[TBL] [Abstract][Full Text] [Related]
13. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
[TBL] [Abstract][Full Text] [Related]
14. Value of MR diffusion imaging in hepatic fibrosis and its correlations with serum indices.
Hu XR; Cui XN; Hu QT; Chen J
World J Gastroenterol; 2014 Jun; 20(24):7964-70. PubMed ID: 24976733
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic value of five serum markers for liver fibrosis].
Luo R; Yang S; Xie J; Zhao Z; He Y; Yao J
Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):148-50. PubMed ID: 11412388
[TBL] [Abstract][Full Text] [Related]
16. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
Ding XJ; Li SB; Li SZ; Liu HS; Liu B; Xu FM; Gu RW
Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of salvianolic acid B on CCl(4)-induced hepatic fibrosis through regulating NF-κB/IκBα signaling.
Wang R; Yu XY; Guo ZY; Wang YJ; Wu Y; Yuan YF
J Ethnopharmacol; 2012 Dec; 144(3):592-8. PubMed ID: 23041223
[TBL] [Abstract][Full Text] [Related]
18. [Liver fibrosis indexes in nonalcoholic fatty liver disease].
Deng YQ; Fan XF
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2003 Jun; 32(3):241-3. PubMed ID: 12881873
[TBL] [Abstract][Full Text] [Related]
19. [Experimental study on the anti-liver fibrosis effect of guzhang tablet in rats].
Zhao YY; Liu FZ; Yang XP
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Dec; 23(12):922-5. PubMed ID: 14714366
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of tissue inhibitor of metalloproteinase-1 are correlated with liver fibrosis in patients with chronic hepatitis B.
Zhu CL; Li WT; Li Y; Gao RT
J Dig Dis; 2012 Nov; 13(11):558-63. PubMed ID: 23107442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
